TABLE 2.
Baseline of patients in the WMU-THCA cohort.
| Level | Overall | |
| n | 79 | |
| Age (median [IQR]) | 43.00 [33.00, 52.00] | |
| Gender (%) | Female | 59 (74.7) |
| Male | 20 (25.3) | |
| Pathology T stage (%) | T1 | 60 (75.9) |
| T2 | 13 (16.5) | |
| T3 | 6 (7.6) | |
| Extrathyroidal extension (%) | None | 65 (82.3) |
| Yes | 14 (17.7) | |
| Pathology N stage (%) | N0 | 31 (39.2) |
| N1 | 48 (60.8) | |
| BRAFV600E (%) | Negative | 11 (13.9) |
| Positive | 48 (60.8) | |
| AJCC7 stage (%) | Stage I | 30 (38.0) |
| Stage II | 46 (58.2) | |
| Stage III | 3 (3.8) | |
| Envelop invasion (%) | No | 24 (30.3) |
| Yes | 8 (10.1) | |
| Multifocality (%) | Multifocal | 33 (41.8) |
| Unifocal | 46 (58.2) |